Caldwell Trust CO Ionis Pharmaceuticals Inc Transaction History

Caldwell Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 01, 2025	SELL	$37.12 - $46.52 $148,480 - $186,080	-4,000 Closed	0 $0
Q3 2022 Oct 01, 2025	BUY	$36.54 - $48.66 $146,160 - $194,640	4,000 New	4,000 $177 Million
Q1 2022 Oct 01, 2025	BUY	$29.88 - $37.04 $119,520 - $148,160	4,000 New	4,000 $148 Million
Q1 2021 Oct 02, 2025	BUY	$42.51 - $63.78 $170,040 - $255,120	4,000 New	4,000 $180 Million
Q4 2020 Oct 02, 2025	BUY	$45.3 - $60.27 $181,200 - $241,080	4,000 New	4,000 $226 Million

Q1 2020 Oct 02, 2025	BUY	$41.6 - $63.4 $166,400 - $253,600	4,000 New	4,000 $189 Million
Q4 2019 Oct 06, 2025	BUY	$53.85 - $65.27 $215,400 - $261,079	4,000 New	4,000 $242 Million

516

154M

2.69M

1.03M

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $10.2B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

Stay updated on Caldwell Trust CO with notifications on news.